Top Markets
Coin of the day
Becton, Dickinson and Company Becton, Dickinson and Company

Becton, Dickinson and Company

BDX
Peringkat dalam Saham #389
Becton, Dickinson and Company develops, manufactures, and sells medical... Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
Harga Saham
$154.51
Kapitalisasi Pasar
$55.98B
Perubahan (1 hari)
-1.82%
Perubahan (1 tahun)
-32.08%
Negara
US
Perdagangan Becton, Dickinson and Company (BDX)

Kategori

Rasio P/S untuk Becton, Dickinson and Company (BDX)
Rasio P/S per March 2026 TTM: 2.63
Menurut laporan keuangan dan harga saham terbaru dari Becton, Dickinson and Company, rasio P/S saat ini (TTM) adalah 2.63. Pada akhir 2024, rasio P/S perusahaan adalah 3.46.
Riwayat rasio P/S untuk Becton, Dickinson and Company dari 2000 hingga 2026
Rasio P/S pada akhir setiap tahun
Tahun Rasio P/S Mengubah
2026 (TTM) 2.63 7.06%
2025 2.46 -29.05%
2024 3.46 -9.38%
2023 3.82 13.52%
2022 3.37 -7.13%
2021 3.62 -7.95%
2020 3.94 2.25%
2019 3.85 -7.58%
2018 4.17 20.46%
2017 3.46 15.84%
2016 2.99 17.19%
2015 2.55 0.33%
2014 2.54 7.48%
2013 2.36 15.16%
2012 2.05 -1.58%
2011 2.08 -12.26%
2010 2.38 1.52%
2009 2.34 -13.39%
2008 2.70 -13.13%
2007 3.11 4.69%
2006 2.97 25.13%
2005 2.37 -7.55%
2004 2.57 27.93%
2003 2.01 11.28%
2002 1.80 -26.44%
2001 2.45 36.00%
2000 1.80 0.00%
Rasio P/S untuk perusahaan sejenis atau pesaing
Perusahaan Rasio P/S Perbedaan Rasio P/S Negara
16.66 532.59%
US
4.09 55.39%
DE
10.24 288.95%
JP
3.62 37.59%
CH
6.24 137.01%
US